Watchlist Price Alert

Acurx Pharmaceuticals Inc... (ACXP)

NASDAQ: ACXP · Real-Time Price · USD

0.36

0.02 (5.57%)

At close: May 07, 2025, 1:43 PM

Acurx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-14.1M	-14.58M	-12.09M	-12.75M	-4.6M	-5.93M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	3.44M	3.77M	3.3M	6.74M	1.27M	900.43K
Other Working Capital	284.09K	30.02K	30.35K	-387.84M	-801.17K	1.05M
Other Non-Cash Items	n/a	980.75K	3.3M	850.26K	781.7K	900.43K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	284.09K	30.02K	1.25M	141.28K	-801.17K	1.05M
Operating Cash Flow	-10.38M	-9.8M	-7.54M	-5.01M	-3.35M	-3.99M
Capital Expenditures	n/a	5.00	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	66.5K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	210.2K	2.22M	13.00	n/a	n/a	n/a
Financial Cash Flow	6.62M	8.16M	3.7M	14.8M	4.04M	4.46M
Net Cash Flow	-3.77M	-1.64M	-3.85M	9.78M	692.09K	470.17K
Free Cash Flow	-10.38M	-9.8M	-7.54M	-5.01M	-3.35M	-3.99M